Routt, E. 2019. Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. SKIN The Journal of Cutaneous Medicine. 3, 2 (Mar. 2019), 150–151. DOI:https://doi.org/10.25251/skin.3.2.32.